Alivus Life Sciences Ltd. IPO

It is a wholly-owned subsidiary of Glenmark Pharma and the leading manufacturer of selected APIs in chronic therapeutic areas.

Alivus Life Sciences Ltd. IPO Details

Check out the issue details for Alivus Life Sciences Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 720

Price Band

₹ 695 - 720

Issue Size

1513.6 Cr.

Issue Type

Book Built

Open

2021-07-27

Close

2021-07-29

Listingprice

₹ 750

ListingGain

4.17%

Listing Date

2021-08-06

CMP

₹ 944.8

Current Return

31.22%

Company Financials

You can get the following financial statements of Alivus Life Sciences Ltd. as of now.

The valuation of Glenmark Life Sciences IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 720
Total Shares 12.25 Cr
Market Cap 8820 Cr
EPS  Rs 28.69 
PE Ratio 25x
Industry PE 37x

 

Glenmark Life Sciences IPO issue size is 1513.6 Cr. 

Issue Amount
Fresh Issue 1060 Cr
Offer For Sale 453.6 Cr

 

An Individual can apply for a minimum 1 lot of 20 shares and a maximum of 13 lots of 260 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 20 Rs 14,400
 Maximum 13 260 Rs 1,87,200

 

Glenmark Life Sciences IPO is subscribed 44.17 times till 29th July. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 36.97 Times
Non-Institutional Minimum 15% 122.54 Times
Retail Individual Minimum 35% 14.63 Times
Total 100% 44.17 Times

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Glenmark Life Sciences IPO:

Schedule Date
Basis of Allotment 03 August 2021
Refunds 04 August 2021
Credit to Demat Account 05 August 2021
IPO Listing Date 06 August 2021

When the allotment is out, you can check it from the registrar's website. Find the Glenmark Life Sciences IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 1885.17 2123.21 2161.22 2283.21 2386.88
Total Expenditure 1294.09 1507.15 1518.93 1608.97 1704.3
Operating Profit 591.07 616.06 642.29 674.25 682.58
Other Income 0.81 14.7 28.96 12.04 34.57
Interest 87.55 27.96 0.55 1.55 2.41
Depreciation 33.39 37.88 42.09 53.45 60.61
Exceptional Items 0 0 0 0 0
Profit Before Tax 470.94 564.93 628.61 631.29 654.13
Provision for Tax 119.36 146.2 161.65 160.4 168.5
Net Profit 351.58 418.72 466.96 470.89 485.63
Adjusted EPS (Rs.) 3.26 3.42 3.81 3.84 3.96

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.96 24.51 24.51 24.51 24.51
Total Reserves 750.79 2029.81 2113.7 2307.82 2792.87
Borrowings 0 0 0 0 0
Other N/C liabilities 22.89 32.7 67.4 756.95 466.05
Current liabilities 1444.93 746.8 1014.89 438.77 470.16
Total Liabilities 2220.57 2833.81 3220.49 3528.05 3753.59
Assets
Net Block 572.8 589.76 780.63 805.06 954.95
Capital WIP 14.1 91.69 49.35 101.19 94.25
Intangible WIP 0 5.27 12.26 4.8 7.66
Investments 0.08 0.08 0.08 0.08 0.08
Loans & Advances 11.06 19.63 9.49 700.92 361.49
Other N/C Assets 0 0 0 0 0
Current Assets 1622.53 2127.39 2368.68 1916 2335.16
Total Assets 2220.57 2833.81 3220.49 3528.05 3753.59
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Other Income 5.49 8.53 10.46 10.09 8.99
Profit Before Tax 150.24 127.46 185.15 191.29 162.98
Tax 38.76 32.14 48.19 49.42 41.45
Profit After Tax 111.48 95.32 136.96 141.87 121.54
Adjusted EPS (Rs) 9.1 7.78 11.18 11.58 9.91

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 74.94 0
Mar 2025 74.99 0
Dec 2024 75 0
Sep 2024 75 0
Jun 2024 82.85 9.47
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 470.94 564.93 628.61 631.29 654.13
Adjustment 133.31 70.99 44.62 79.27 80.72
Changes in Assets & Liabilities -107.58 99.84 -213.66 -134.08 -180.38
Tax Paid -108.56 -138.17 -153.57 -162.96 -162.95
Operating Cash Flow 388.11 597.59 306.01 413.52 391.52
Investing Cash Flow -68.73 -122.23 -146.75 -116.48 -615.65
Financing Cash Flow -213.78 -78.8 -387.59 -279.44 -6.23
Net Cash Flow 105.6 396.56 -228.33 17.59 -230.35
X